8-K: Accelerant Holdings to be Acquired by Thoma Bravo for $4B+

Sentiment:

Merger Announcement and Quarterly Results


Accelerant Holdings announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valued at over $4 billion, while also reporting strong Q2 2026 financial results.

Summary

  • Accelerant Holdings announced its Q2 2026 financial results, showing a 23% year-over-year increase in Exchange Written Premium to $1.32 billion.
  • The company reported pre-tax income of $87 million and net income of $80 million, with net income per diluted share at $0.36.
  • Adjusted net income increased by 165% to $70 million, and adjusted net income per diluted share rose to $0.32.
  • Adjusted EBITDA reached $93.1 million, with an improved margin of 30.6%.
  • Accelerant has entered into a definitive agreement to be acquired by Thoma Bravo for $20.25 per share in cash, representing a 49% premium.
  • The transaction has an enterprise value exceeding $4 billion and is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
  • The company has cancelled its Q2 2026 earnings conference call and will not provide Q3 or full-year 2026 guidance due to the pending acquisition.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive due to strong operational and financial performance in Q2 2026, alongside a significant strategic development with the acquisition by Thoma Bravo, which offers a substantial premium to shareholders.

Positives

  • Exchange Written Premium grew 23% year-over-year to $1.32 billion in Q2 2026.
  • Third-party direct written premium accounted for 47% of Exchange Written Premium volume.
  • Pre-tax income was $87 million, and net income was $80 million.
  • Adjusted net income increased by 165% to $70 million, and adjusted net income per diluted share increased by 146% to $0.32.
  • Adjusted EBITDA was $93.1 million, with a margin of 30.6%, up from 29.0% in the prior year.
  • The acquisition by Thoma Bravo offers shareholders $20.25 per share in cash, a 49% premium over the previous day's closing price.
  • The transaction has an enterprise value exceeding $4 billion.
  • The company repurchased 4,725,968 Class A common shares for $66 million.

Negatives

  • The company will not host an earnings conference call or provide Q3 or full-year 2026 guidance due to the pending acquisition.
  • Net revenue retention decreased from 151% in Q2 2025 to 111% in Q2 2026.
  • Accelerant direct written premium decreased from 73% to 53% of Exchange Written Premium volume year-over-year.

Risks

  • The risk that the Merger may not be completed in a timely manner or at all, which may adversely affect the business and the price of Class A common shares.
  • The risk that a governmental or regulatory approval required for the Merger is not obtained or is obtained subject to unanticipated conditions.
  • The effect of the pendency of the Merger on business relationships, operating results, and business generally.
  • Certain restrictions during the pendency of the Merger may impact the ability to pursue certain business opportunities or strategic transactions.
  • Risks that the Merger disrupts current plans and operations or diverts management's attention from ongoing business operations.
  • The outcome of any legal proceedings that may be instituted against the parties to the Merger Agreement.
  • The Company's ability to retain, hire, and integrate skilled personnel, and maintain relationships with key business partners and customers in light of the proposed Merger.
  • Unexpected costs, charges, or expenses resulting from the Merger.

Future Outlook

Due to the pending acquisition by Thoma Bravo, Accelerant will not be providing guidance for the third quarter of 2026 or the full year of 2026.

Management Comments

  • "I am proud of what the Accelerant teams has accomplished, and I believe partnering with Thoma Bravo with their expertise, and vast financial and strategic resources will further position our unique, data fueled platform to be the rails on which specialty insurance runs."
  • "We had a great second quarter financially, operationally, and strategically. Financially, we delivered strong growth in exchange written premium, third-party premium, and adjusted EBITDA."
  • "Our second quarter financial results highlight the attractive growth and durability of our business. Exchange Written Premium grew 23% year-over-year and trailing twelve months premiums are now $4.6 billion."
  • "We look forward to working with Thoma Bravo to grow the business alongside our employees, Members, and Risk Capital Partners."
  • "We are pleased to have reached this agreement with Thoma Bravo. The Special Committee believes this transaction recognizes the valuable platform and ecosystem that the Accelerant team has built, and provides immediate value to shareholders at a substantial premium."
  • "We have immense admiration for Jeff, his team and the business theyve built. As the MGA market continues to grow, underwriters are looking for a committed technology-forward partner who can unlock rapid program growth and underwriting innovation."
  • "Accelerant has built something rare in specialty insurance. Its risk exchange connects underwriters with risk capital and gives both sides the data to price risk better than either could alone. We look forward to partnering with Jeff and the team to invest behind the technology, data and capital capacity to support Accelerants next phase of growth."

Industry Context

StockSavvy.ai notes that the acquisition of Accelerant Holdings by Thoma Bravo, a prominent software-focused private equity firm, aligns with a broader trend of consolidation and significant investment in technology-driven platforms within the specialty insurance sector. Thoma Bravo's focus on software and data aligns with Accelerant's strategy of leveraging data analytics and AI for risk exchange.

Comparison to Industry Standards

  • The 23% year-over-year growth in Exchange Written Premium for Q2 2026 indicates strong performance relative to the broader insurance market, which typically experiences more moderate growth rates.
  • The Adjusted EBITDA margin of 30.6% suggests efficient operations and strong profitability, which is a key benchmark for technology-enabled financial services companies.
  • The acquisition price of $20.25 per share, representing a 49% premium, is a significant indicator of the perceived value and growth potential of Accelerant within the specialty insurance technology space, often exceeding typical acquisition premiums for mature companies.
  • The focus on a 'data-driven risk exchange platform' positions Accelerant as an innovator, aiming to disrupt traditional insurance models, a strategy increasingly adopted by forward-thinking companies in the insurtech and specialty insurance markets.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Special Committee FormationA Special Committee comprised solely of independent and disinterested directors was established to review and consider the transaction with Thoma Bravo.Prior to August 13, 2026Ensures a thorough and objective review of the acquisition proposal, safeguarding shareholder interests.
Board ApprovalThe Special Committee unanimously recommended approving the transaction, which was then unanimously approved by Accelerant's Board of Directors.Prior to August 13, 2026Demonstrates strong internal endorsement of the acquisition terms and strategic direction.

Stakeholder Impact

  • Shareholders: Will receive $20.25 per share in cash, representing a 49% premium, providing immediate and substantial value realization.
  • Employees: May face uncertainty regarding future roles and integration with Thoma Bravo, though Thoma Bravo's expertise in software and data suggests potential for continued investment in talent.
  • Customers and Members: Business operations are expected to continue, with potential for enhanced investment in the platform's technology and services under Thoma Bravo's ownership.
  • Risk Capital Partners: May see continued or enhanced opportunities for capital deployment through Accelerant's platform, supported by Thoma Bravo's financial backing.
  • Creditors: The transaction is not subject to a financing condition, indicating that debt obligations are expected to be managed or refinanced as part of the acquisition.

Next Steps

  • Accelerant shareholders will vote on the proposed merger agreement.
  • The transaction is subject to customary closing conditions, including required regulatory approvals.
  • Accelerant intends to file a proxy statement with the SEC in connection with a special meeting of shareholders.
  • The company and participants in the merger intend to file a transaction statement on Schedule 13E-3, if required.
  • Upon completion, Accelerant will become a private company, and its common shares will no longer be listed on the New York Stock Exchange.

Key Dates

DateDescription
2018-01-01Founding of Accelerant.
2025-03-18Filing of Annual Report on Form 10-K for the year ended December 31, 2025.
2026-03-30Filing of proxy statement for the 2026 annual general meeting of shareholders.
2026-08-13Date of the Form 8-K filing and issuance of earnings release and merger announcement press releases.
2026-08-13Original scheduled date for the Q2 2026 earnings conference call.
2027-01-01Expected closing of the merger transaction (first half of 2027).

Recommendation

hold

The acquisition at a significant premium provides a clear exit for shareholders, making 'hold' appropriate to capture the offer price. For existing shareholders, the offer represents a strong realization of value. For potential new investors, the stock is unlikely to trade significantly above the offer price due to the certainty of the all-cash deal, making it less attractive for speculative upside.

Keywords

specialty insurance, risk exchange, merger, acquisition, Thoma Bravo, private equity, earnings, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.